Your session is about to expire
← Back to Search
Local Anesthetic
ESPB Solutions for Breast Cancer
Phase 2
Waitlist Available
Research Sponsored by Tufts Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 hours
Awards & highlights
Summary
This trial will compare pain scores of two different methods of pain management for subjects undergoing bilateral surgical intervention for breast cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 72 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 hours
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Pain Score at 48 hours
Secondary study objectives
Pain Scores at 6, 12, 18, 24, 30, 38, 42, and 72 hours
Trial Design
2Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
Control arm will receive standard of care solution for the ESPB block
Group II: Liposomal BupivicaineActive Control1 Intervention
Liposomal Bupivicaine arm will receive Liposomal Bupivicaine for the ESPB block
Find a Location
Who is running the clinical trial?
Tufts Medical CenterLead Sponsor
261 Previous Clinical Trials
264,120 Total Patients Enrolled
4 Trials studying Breast Cancer
1,776 Patients Enrolled for Breast Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are pregnant.Newborns who may not survive.You are allergic or have a bad reaction to the study medication.Babies who are born without signs of life.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Liposomal Bupivicaine
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger